BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 9510170)

  • 1. Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4.
    Horspool JH; Perrin PJ; Woodcock JB; Cox JH; King CL; June CH; Harlan DM; St Louis DC; Lee KP
    J Immunol; 1998 Mar; 160(6):2706-14. PubMed ID: 9510170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
    Mukherjee S; Maiti PK; Nandi D
    J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and contribution of B7-1 (CD80) and B7-2 (CD86) in the early immune response to Leishmania major infection.
    Elloso MM; Scott P
    J Immunol; 1999 Jun; 162(11):6708-15. PubMed ID: 10352289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that induction of tolerance in vivo involves active signaling via a B7 ligand-dependent mechanism: CTLA4-Ig protects V beta 8+ T cells from tolerance induction by the superantigen staphylococcal enterotoxin B.
    Lane P; Haller C; McConnell F
    Eur J Immunol; 1996 Apr; 26(4):858-62. PubMed ID: 8625979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Costimulatory molecules in autoimmunity: role of CD28/CTLA4-CD80/CD86].
    Nakajima A; Azuma M
    Nihon Rinsho; 1997 Jun; 55(6):1419-24. PubMed ID: 9200926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 induces functional expression of CTLA-4, a second receptor for B7.
    Damle NK; Klussman K; Leytze G; Myrdal S; Aruffo A; Ledbetter JA; Linsley PS
    J Immunol; 1994 Mar; 152(6):2686-97. PubMed ID: 7511623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
    J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization.
    Gajewski TF; Fallarino F; Uyttenhove C; Boon T
    J Immunol; 1996 Apr; 156(8):2909-17. PubMed ID: 8609411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-CD28/CTLA-4 costimulatory pathways are required for the development of T helper cell 2-mediated allergic airway responses to inhaled antigens.
    Keane-Myers A; Gause WC; Linsley PS; Chen SJ; Wills-Karp M
    J Immunol; 1997 Mar; 158(5):2042-9. PubMed ID: 9036947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role of costimulation in the activation of naive antigen-specific TCR transgenic CD8+ T cells in vitro.
    Chai JG; Vendetti S; Bartok I; Schoendorf D; Takacs K; Elliott J; Lechler R; Dyson J
    J Immunol; 1999 Aug; 163(3):1298-305. PubMed ID: 10415027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
    Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
    Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The B7-CD28 superfamily.
    Sharpe AH; Freeman GJ
    Nat Rev Immunol; 2002 Feb; 2(2):116-26. PubMed ID: 11910893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.